|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2006-12-12
|
|
pubmed:abstractText |
As conventional immunotherapy is less efficacious in patients with allergic multi-sensitivities compared with mono-sensitized subjects, new intervention strategies are needed. Therefore, an allergen chimer was genetically engineered for treatment of multi-sensitization with birch and grass pollen on the basis of mucosal tolerance induction.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0105-4538
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
62
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
33-41
|
|
pubmed:meshHeading |
pubmed-meshheading:17156339-Administration, Intranasal,
pubmed-meshheading:17156339-Allergens,
pubmed-meshheading:17156339-Animals,
pubmed-meshheading:17156339-Betula,
pubmed-meshheading:17156339-Desensitization, Immunologic,
pubmed-meshheading:17156339-Female,
pubmed-meshheading:17156339-Hypersensitivity,
pubmed-meshheading:17156339-Immunity, Mucosal,
pubmed-meshheading:17156339-Mice,
pubmed-meshheading:17156339-Mice, Inbred BALB C,
pubmed-meshheading:17156339-Models, Molecular,
pubmed-meshheading:17156339-Poaceae,
pubmed-meshheading:17156339-Pollen,
pubmed-meshheading:17156339-Recombinant Fusion Proteins,
pubmed-meshheading:17156339-Vaccines, Subunit
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
A recombinant allergen chimer as novel mucosal vaccine candidate for prevention of multi-sensitivities.
|
|
pubmed:affiliation |
Department of Specific Prophylaxis and Tropical Medicine, Center for Physiology and Pathophysiology, Medical University of Vienna, Vienna, Austria.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Evaluation Studies
|
